Carelon — Cyborg Score 7/10

Strong
Value-based care and integrated healthcare services

Strategic Profile

Carelon is the healthcare services operations arm of Elevance Health, including pharmacy services, behavioral health, value-based care, and care delivery capabilities, playing a critical role in advancing the Company's strategy to lower the cost of care. Specialty pharmacy, CareBridge and integrated medical-pharmacy solutions continue to gain traction, supporting Carelon's long-term growth prospects as employers seek more cost-effective healthcare solutions.

Cyborg Score Rationale

Specialty pharmacy, CareBridge and integrated medical-pharmacy solutions continue to gain traction, supporting Carelon's long-term growth prospects. Carelon is becoming a major growth driver for Elevance Health, boosting revenues, care efficiency and long-term earnings potential despite near-term investment pressure. However, Carelon's first-quarter 2026 operating gain declined 3.8% year over year due to lower affiliated health plan membership and continued investments in expanding risk-based programs.

Top Insights

  • As of March 31, 2026, Carelon has 3,196 employees
  • As of April 2026, Carelon's annual revenue is estimated to be $5B
  • Elevance Health raised its 2026 adjusted EPS guidance to at least $26.75 (Q1 2026)
  • In February 2026, Elevance Health announced management changes with Peter D. Haytaian transitioning from Executive Vice President and President of Carelon effective May 4, 2026

Named Competitors

  • Optum — Integrated health services and pharmacy benefits
  • CenterWell — Integrated primary care, home health and pharmacy
  • CVS Health Services — Pharmacy, health plans and care delivery integration

Recent Developments

  • (June 2026) Carelon's operating performance under review as leadership transition completes, with strategic focus on value-based care expansion
  • (February 2026) Elevance Health restructures Carelon oversight with CFO Mark Kaye expanding responsibilities to include Carelon operations
  • (Q1 2026) Carelon's specialty pharmacy and integrated medical-pharmacy solutions gaining market traction among employers seeking cost-effective solutions

Open the full interactive Carelon report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →